Valion Bio Sets 30-Day Agenda for Pipeline, Velocity Bioworks and Shareholder Value

Valion Bio outlined a 30-day agenda focused on advancing its clinical pipeline, growing Velocity Bioworks and exploring strategic opportunities.Key Highlights:Original SEC Filing: Valion Bio, Inc. [ VBIO ] - 8-K - Oct. 22, 2026This is an AI-powered summary. It may contain inaccuracies. Consider ver…